KPJ HEALTHCARE |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.91 MYR | -1.04% |
|
-2.55% | +32.64% |
| Sales 2023 | 3.5B 732M | Sales 2024 * | 3.61B 753M | Capitalization | 8.16B 1.7B |
|---|---|---|---|---|---|
| Net income 2023 | 270M 56.37M | Net income 2024 * | 284M 59.29M | EV / Sales 2023 | 2.11 x |
| Net Debt 2023 | 1.13B 235M | Net Debt 2024 * | 1.13B 236M | EV / Sales 2024 * | 2.58 x |
| P/E ratio 2023 |
23.8
x | P/E ratio 2024 * |
30
x | Employees | - |
| Yield 2023 |
2.33% | Yield 2024 * |
1.77% | Free-Float | 40.35% |
More Fundamentals
* Assessed data
More news
| 1 day | -1.04% | ||
| 1 week | -2.55% | ||
| Current month | -0.52% | ||
| 1 month | +4.37% | ||
| 3 months | +26.49% | ||
| 6 months | +59.17% | ||
| Current year | +32.64% |
1 week
1.89
1.95
1 month
1.831.98
Current year
1.411.98
1 year
1.081.98
3 years
0.791.98
5 years
0.721.98
10 years
0.721.98
| Managers | Title | Age | Since |
|---|---|---|---|
Keat Chyuan Chin
CEO | Chief Executive Officer | 50 | 23-08-31 |
| President | 50 | 22-03-31 | |
| Director of Finance/CFO | 51 | 07-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 61 | 20-05-06 | |
| Director/Board Member | 55 | 20-03-31 | |
| Director/Board Member | 49 | 20-05-06 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.41% | 2 M€ | -14.14% | ||
| 0.01% | 4 M€ | -4.41% | - | |
| 0.00% | 117 M€ | -0.62% | - | |
| 0.00% | 34 M€ | +1.37% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-15 | 1.91 | -1.04% | 17,012,200 |
| 24-04-12 | 1.93 | +1.05% | 6,508,800 |
| 24-04-09 | 1.91 | -2.55% | 7,470,700 |
End-of-day quote BURSA MALAYSIA, April 14, 2024
More quotes
KPJ Healthcare Berhad is a Malaysia-based investment holding company. The Company is engaged in the provision of management services to subsidiaries. The principal activities of its subsidiaries are mainly the operation of specialist hospitals. The Company's segments include Malaysia and Others. Malaysia segment is engaged in all healthcare activities, including private hospitals, pathology and laboratory services and distribution of pharmaceutical, medical and consumer healthcare products. Others segment is involved in provision of hospital and aged care services in Thailand, Bangladesh and Australia, private university college of nursing and allied health and sale of hospital merchandise and other similar activities. Its subsidiaries include Kumpulan Perubatan (Johor) Sdn Bhd, Point Zone (M) Sdn Bhd, Tawakal Holdings Sdn Bhd, Johor Specialist Hospital Sdn Bhd, Pusat Pakar Tawakal Sdn Bhd, Ipoh Specialist Hospital Sdn Bhd, Puteri Specialist Hospital (Johor) Sdn Bhd and other.
Calendar
2024-05-29
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
1.91
MYR
Average target price
1.786
MYR
Spread / Average Target
-6.51%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +32.64% | 1.74B | |
| -21.62% | 15.98B | |
| 0.00% | 11.99B | |
| 0.00% | 11.11B | |
| +11.06% | 10.85B | |
| +19.69% | 8.08B | |
| -2.15% | 7.67B | |
| +24.33% | 7.41B | |
| +4.96% | 6.75B | |
| +43.91% | 4.44B |
- Stock Market
- Equities
- KPJ Stock
